| CURRENT MODELS OF THROMBOPOIESIS
While MKs are clearly identified as immediate progenitors of platelets, the way how platelet biogenesis occurs, has remained a matter of debate during the last five decades, and even current observations challenge our thinking about platelet production across the endothelial barrier.
Platelets have an overall short life span of about 8-10 days in humans and 5-7 days in mice. Old platelets are sequestered by the liver and spleen and the population of platelets is permanently replenished. In addition, blood loss or episodes of bleeding might induce an additional production to compensate for the loss. The concentration of circulating platelets is rather tightly regulated and controlled by the thrombopoietin (THPO) axis. 4 THPO is typically produced constitutively by hepatocytes in the liver (and too a much lesser extent in the kidney or bone marrow stroma cells) and tor in the liver where they modulate THPO production. 5 Our current understanding of hematopoiesis in the bone marrow is based on findings that a pool of hematopoietic stem cells (HSCs) resides in a specific, protected microenvironment, typically under hypoxic conditions. Under steady state conditions HSCs are typically quiescent, in the G0 phase. A low rate of both symmetric cell divisions, which allow to maintain and replenish this stem cell pool, as well as asymmetric cell divisions that will lead into the generation of more committed progenitor cells. These precursors will finally give rise to cells of all blood lineages. All mature, circulating blood cells are thus generated from these progenitor cells within the bone marrow compartment, while the endothelial layer of the sinusoidal vessels builds the critical interface and is considered the blood-bone marrow barrier. This concept, however, requires that the HSCs migrate out of the "stem cell niche," start to differentiate (and proliferate), and steadily migrate toward the vascular niche at the bone marrow sinusoids, where finally mature MKs shed platelets into the circulation. This model is typically referred to as the "flow model," while alternative models with a "protoplatelet hypothesis" have been suggested. The resulting "cytoplasmic fragmentation model" addresses how "platelet territories," 6 despite the lack of detectable polymerized microtubule filaments, remain true future platelets. [7] [8] [9] These conflicting models are based on distinct experimental models and imaging approaches that finally need to translate into a coherent model of platelet biogenesis. 
| CAUGHT IN STILL LIFE: ELECTRON MICROSCOPY
Thin layer transmission electron microscopy (TEM) has been the imaging approach of choice for decades and high-quality images of megakaryocytes and platelets have shaped our thinking about the megakaryocytes as precursors of platelets. 16 The internal membrane system has first been considered to delineate single platelet territories 6, 17 and designated the "demarcation membrane system" (DMS).
Work by Radley has realized that this term is a misnomer, 18, 19 but alternative names like "invagination membrane system" have not really been used in the field, including rather novel approaches to further characterize this membrane reservoir as required for platelet production. [20] [21] [22] [23] [24] While classic TEM allows the required ultraresolution to capture the process of platelet biogenesis, it harbors several disadvantages: the total field is rather limited and the sample preparation is overall tedious. Moreover, while platelets and MKs in suspension are readily pelleted prior to subjection to TEM, the interaction of MK with the vessel wall in situ is additionally hampered by the mineralized bone, which typically requires decalcification for optimal sample processing. 
| CINEMICROGRAPHY: IMAGING THE ELUSIVE
The primary challenge was to study the dynamic process of platelet biogenesis at a virtually inaccessible site within the bone marrow by static microscopy and image processing. Haller and
Radley describe the efforts to study platelet production from MKs of various species, including rats, mice, dogs, rabbits, or humans, and different organs (bone marrow, spleen). They conclude the "presence of blebs or small protrusions of the megakaryocyte surface to represent the development of platelets which are destined to be released by a budding mechanism." 26 Both investigators adopted an approach to implement a time-resolved "cinemicrog- and elongation to increase the number of free tips, where mature and nascent platelets are shed. 28 This model has become the paradigm of platelet biogenesis and has been reviewed extensively.
Its elegant approach and comprehensive model system allowed to use transgenic mouse models to identify the key transcription factors (like p45 NF-E2 ), cytoskeletal proteins (like beta1-tubulin) or regulatory proteins (like SLPI) and many to follow. [29] [30] [31] However,
proplatelet formation appeared to be undirected, even when the starting point of proplatelet formation seemed to be at one pole of the MK. By serendipity, the combination of cranial intravital two-photon microscopy (2PM) to study processes in the bone marrow of living mice, with a suitable mouse model where a significant fraction of MKs were intrinsically fluorescent, led to the first description of platelet biogenesis in the living mouse. 32 The Two-photon microscopy has afterwards been used by a few groups interested in MKs to study the effect of drugs (like dasatinib) on thrombopoiesis in vivo 15 or to investigate knock-out mice for platelet production. [37] [38] [39] [40] MKs were visualized using either reporter strains that express fluorescent proteins specifically in MKs and platelets, 15, 37, 41 or using fluorophore-conjugated antibody derivatives against the von Willebrand receptor subunit GPIX prior to imaging. This antibody is widely used in in vivo platelet studies and is described not to interfere with platelets or megakaryocytes in these settings. 42 The vessel lumen is usually stained with fluorophore-conjugated high-molecular weight dextrans, quantum dots (see Figure 1 ) or fluorophore-conjugated BSA, while we do use anti-CD105 (anti-endoglin) antibodies to label the endothelial lining, in addition to the vessel lumen. [38] [39] [40] [42] [43] [44] 
TA B L E 1 Advantages and disadvantages of methods for imaging platelet biogenesis

| RECENT INSIGHTS INTO PLATELET BIOGENESIS
The novel applications of intravital microscopy provide many possibilities to study platelet biogenesis in the living mouse. However, the cranial window, which is typically used, has also some limita- 49 The ineffective platelet production in CK2β-deficient animals resulted in a macrothrombocytopenia, which was further caused by a slightly reduced platelet lifespan. 47 Reduced MK stability and elevated ectopic platelet release was also observed in mice lacking the adhesion and degranulation promoting adaptor protein ADAP, suggesting a critical role of this adaptor in the final stages of platelet production. 48 The lung capillary bed might act as a filter 55 and thus indirectly contribute to platelet production, while circulating MKs in distinct vessels remain rare. 56 Imaging of the lung in mice has been technically challenging. A recent study has solved this technical problem and provides evidence for MKs in the lung and platelet production by ectopic lung transplantation. 57 However, their mathematical extrapolation that MKs in the lung contribute to 50% to the cir- of localization microscopy. While it is currently unclear, which of these improvements will finally translate into microscopy approaches in our field, we can be assured that even some of the current innovations will radically change the way how we are able to image samples, both in vitro and in vivo (Table 1) . A recent review provides a comprehensive overview of next generation microscopy apporaches for imaging biological specimens. 59 One of several outstanding and promising approaches is the "correlative light and electron microscopy" (CLEM), which allows to identify the region of interest with the help of fluorescence microscopy. Subsequently, the ultrastructure can be analyzed by serial sectioning tomography and aligned electron microscopy.
While this approach is still mainly restricted to fixed samples, it can be applied in intravital approaches and might in the foreseeable future allow to visualize certain aspects of polarization in MKs in vitro.
Another step forward is the combination of single molecule localization microscopy (SMLM) imaging with transgenic tags that can be brought into cells with the help of the CRISPR-Cas9-system as recently demonstrated with cell lines. 60 In the long run this system can be expanded to transiently transfecting MKs in vitro, or even used to generate transgenic animals thereby allowing single molecule imaging of platelet biogenesis.
| CONCLUSIONS
The transformation of megakaryocytes to circulating platelets is a fascinating cell biological phenomenon and its understanding clinically highly relevant. In order to modulate this process, we need to identify the key players at the cellular and molecular level and characterize their interactions. Intravital microscopy has opened a huge door that allows us to study suitable mouse models by advanced imaging technologies. Our current thinking, however, how (and where) platelet biogenesis occurs under physiological or pathophysiological conditions, affects the way how experiments are performed and into which organs we look in the first place.
Imaging through the skull into the bone marrow has led to a better understanding of cellular behavior for many cell types and has refined our thinking of platelet biogenesis, at least in the mouse.
Several approaches will address the technical obstacle of a limited visual field. Other organs like liver, spleen, or the lung have already been adopted for intravital microscopy and will provide new insights-and by this-also produce many more questions.
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